An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies
Open Access
- 2 March 2007
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 136 (6) , 806-813
Abstract
Summary: Chromosome rearrangements involving band 3q26.2 are associated with myeloid malignancies, aberrant expression of the human ecotropic virus integration site‐1 (EVI1) gene, an unfavourable prognosis and an aggressive clinical course. The 3q26.2 rearrangements are characteristically heterogeneous and typically difficult to detect in poor quality metaphases. To develop a dual‐colour fluorescence in situ hybridisation (FISH) assay for the detection of 3q26.2/EVI1 aberrations, a series of 10 BAC clones corresponding to the EVI1 gene region were systematically evaluated and narrowed down to two probe sets; one probe set encompassed the EVI1 gene extending centromeric, while the second probe set covered the EVI1 gene and extends telomeric. Both probe sets were evaluated on 35 patient samples with cytogenetically defined 3q26.2 rearrangements collected at various treatment time points, the inv(3)(q21q26.2) Kasumi‐4 cell line, and 10 known negative samples. The two‐probe set strategy identified all samples, despite the vast breakpoint heterogeneity observed. In samples from acute myeloid leukaemia and myelodysplastic syndrome cases, the majority of inversion breakpoints were 3′ to EVI1 whereas 3q26.2 translocation breakpoints frequently mapped 5′ to EVI1. However, two 3q26.2 translocation samples had breakpoints 3′ to EVI1. Most inv(3q) chronic myeloid leukaemia samples showed breakpoints within the EVI1 gene. This study demonstrated that, despite the extensive breakpoint heterogeneity observed with 3q26.2 aberrations, this FISH strategy is effective for the detection of 3q26.2 abnormalities in myeloid malignancies.Keywords
This publication has 17 references indexed in Scilit:
- Fluorescence in situ hybridization studies using BAC clones of the EVI1 locus in hematological malignancies with 3q rearrangementsCancer Genetics and Cytogenetics, 2006
- t(3;21)(q26;q22) in myeloid leukemiaCancer, 2006
- EVI1 and hematopoietic disorders: History and perspectivesGene, 2006
- Multipoint interphase FISH analysis of chromosome 3 abnormalities in 28 childhood AML patientsEuropean Journal of Haematology, 2005
- EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangementsGenes, Chromosomes and Cancer, 2005
- Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemiaLeukemia, 2005
- Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridizationCancer Genetics and Cytogenetics, 2005
- Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemiaBlood, 2003
- Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic featuresThe Hematology Journal, 2002
- The EVI-1 gene — its role in pathogenesis of human leukemiasLeukemia Research, 2000